|
12/27/2006
Abiomed to Ring NASDAQ Closing Bell, Celebrating Regulatory Progress and Global Leadership in Circulatory Care for Acute Heart Failure Patients
12/27/2006
Abiomed to Present at 2007 JPMorgan Healthcare Conference
12/20/2006
Abiomed Announces FDA 510(k) Clearance for New Intra-Aortic Balloon and Development of Integrated Console, the iPulse, for the Balloon, BVS 5000 and AB5000
12/18/2006
Abiomed Announces Positive Reimbursement Recommendation at Medicare Evidence Development & Coverage Advisory Committee Meeting
12/07/2006
Abiomed to Participate on New Heart Technology Panel at 2006 RBC Capital Markets Healthcare Conference
12/04/2006
Abiomed Announces Webcast on Clinical Best Practices for Heart Recovery
11/20/2006
Abiomed to Present at Lazard Capital Markets Third Annual Life Sciences Conference
11/13/2006
Abiomed Announces Five-Year $16+ Million Impella and AB5000 Distribution Agreement with Medix Japan
11/8/2006
Abiomed Announces Fiscal Second Quarter 2007 Results
10/12/2006
Abiomed announces preliminary second quarter revenue
09/27/2006
Abiomed announces online educational session on CMS 2007 Inpatient Prospective Payment System Final Rule
09/19/2006
Abiomed to Present at UBS Global Life Sciences Conference
09/05/2006
Abiomed receives FDA approval of the Abiocor®, the world's first completely self-contained, implantable artificial heart
08/24/2006
Abiomed announces heart recovery technology presentations at international society of rotary blood pumps meeting
08/23/2006
Abiomed to present at Thomas Weisel Partners Healthcare Conference 2006
08/08/2006
Abiomed announces fiscal first quarter 2007 results with revenues up 55% to $13 million
07/26/2006
Abiomed to present at Canaccord Adams 26th Annual Summer Seminar 2006
07/19/2006
Abiomed First Quarter Earnings and Conference Call Notification
07/17/2006
Abiomed Announces Patient Enrollment in Impella 2.5 Pilot Trial
07/11/2006
FDA Approves ABIOMED's New Integrated Off-Pump Cannula
06/27/2006
FDA Approves ABIOMED'S IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems
06/26/2006
ABIOMED Announces Participation in AdvaMed's "Profiles in Progress You Can See" Events
06/21/2006
ABIOMED Appoints Dr. Daniel Raess as Company Medical Advisor
06/07/2006
ABIOMED to Present at Needham & Company's Fifth Annual Biotechnology Conference
06/06/2006
ABIOMED Technology Included in Eight Presentations at American Society for Artificial Internal Organs Conference
05/25/2006
ABIOMED Receives FDA Approval to Commence IMPELLA 2.5 U.S. Trial
05/22/2006
ABIOMED Announces French Regulatory Approval of the AB5000 Circulatory Support System
05/17/2006
ABIOMED Launches Expanded Customer Services for U.S. Hospitals
05/15/2006
ABIOMED Announces Schedule of Events for Breakthrough Impella Technology at EUROPCR Conference in Paris
05/10/2006
ABIOMED to Present at Bank of America Conference
05/08/2006
ABIOMED Announces Record Results
04/20/2006
Key Clinical Data on ABIOMED'S Ventricular Assist Devices Presented at American Society of Extra-Corporeal Technology Conference
04/18/2006
ABIOMED Announces Favorable High-Risk PCI Data on IMPELLA RECOVER LP 2.5 Published in American Journal of Cardiology
03/07/2006
ABIOMED to Showcase Advanced Circulatory Support Devices at American College of Cardiology's Annual Scientific Sessions
02/28/2006
ABIOMED to Present at the SG Cowen & Co. 26th Annual Healthcare Conference
02/03/2006
ABIOMED Announces Expanded Rerimbursement and Distribution in Europe for Impella Recover® Circulatory Support Systems
02/02/2006
ABIOMED Announces Third Quarter of Fiscal 2006 Financial Results
01/26/2006
ABIOMED to Present at Brean Murray, Carret & Co. Small Cap Institutional Investor Conference
01/24/2006
Abiomed to Showcase Suite of Advanced Circulatory Support Devices at Society of Thoracic Surgeons Conference
01/16/2006
ABIOMED Appoints Ronald Dollens as Board Member
01/09/2006
ABIOMED Appoints Dorothy Puhy to Lead Director of its Board
12/19/2005
ABIOMED Appoints Daniel Sutherby as Chief Financial Officer
11/22/2005
ABIOMED to Present at Lazard Life Sciences Conference
11/02/2005
ABIOMED Announces Fiscal 2006 Second Quarter Financial Results
10/25/2005
ABIOMED Announces Data on its Impella Recover LP 2.5 Presented at TCT
10/17/2005
Data on ABIOMED's AB5000 Circulatory Support System Presented at TCT Shows Recovery Possible For Patients With AMI Cardiogenic Shock
10/06/2005
ABIOMED Announces Schedule of Events at Upcoming TCT Conference
09/30/2005
ABIOMED Appoints Louis Lataif to Board of Directors
09/20/2005
ABIOMED to Present at UBS Global Life Sciences Conference
09/14/2005
ABIOMED to Present at Thinkequity Partners 3rd Annual Growth Conference
08/04/2005
ABIOMED Announces Fiscal 2006 First Quarter Financial Results
08/02/2005
ABIOMED Announces Increased Reimbursement From CMS for Successful Recovery of the Native Heart
07/25/2005
Abiomed to Present at Adams Harkness' 25th Annual Summer Seminar
07/11/2005
ABIOMED Appoints Two New Vice Presidents of U.S. Sales
06/24/2005
FDA Advisory Panel Decision
06/15/2005
ABIOMED Elects Michael Minogue Chairman of Board of Directors
05/31/2005
Fiscal Year 2005 Results
05/13/2005
ABIOMED to Present at Banc of America Health Care Conference
05/11/2005
ABIOMED Announces Completion of Its Acquisition of Impella CardioSystems AG
04/27/2005
ABIOMED Announces Execution of a Definitive Agreement to Acquire Impella CardioSystems AG
04/21/2005
FDA Expert Panel to Review ABIOMED’s Fully Self-Contained Artificial Heart
04/08/2005
Ventricular Assist Increases Survival
02/09/2005
34 Year Old Woman’s Heart Recovers
01/31/2005
ABIOMED Reports Fiscal Third Quarter Financial Results
01/25/2005
ABIOMED Provides Clinical Update on AB5000™ Circulatory Support System
01/20/2005
ABIOMED to Present at Piper Jaffray Health Care Conference
01/12/2005
ABIOMED Provides Financial Update
12/30/2004
ABIOMED AB5000 Ventricle Patient Supported for more than 37 days, Saved on Christmas Eve
12/09/2004
ABIOMED Launches New Clinical Education and Service Program
11/11/2004
Frost & Sullivan’s Circulatory Assist Device Technology Leadership Award Conferred on ABIOMED, Inc.
11/05/2004
Fourteenth AbioCor Patient Passes Away
11/01/2004
ABIOMED Reports Fiscal Second Quarter Financial Results
10/29/2004
ABIOMED Launches New Web Site with Enhanced Educational Features
10/26/2004
ABIOMED Achieves Profitability in Second Quarter
10/21/2004
ABIOMED Provides Update on AbioCor
10/13/2004
ABIOMEDs First European AB5000 Patient Recovers
09/27/2004
Thirteenth AbioCor Patient Passes Away
09/19/2004
ABIOMED Announces First European Orders for the AB5000 Circulatory Support System
09/14/2004
ABIOMED Heart Assist Devices Save Critically Ill Heart Patients
09/09/2004
ABIOMED Appoints European General Manager
09/08/2004
ABIOMED Submits for FDA Approval of the AbioCor
08/02/2004
ABIOMED CEO Michael R. Minogue to Present at Wall Street Analyst Forum Conference
07/30/2004
ABIOMED Reports Fiscal First Quarter Financial Results
07/20/2004
94% of U.S.News & World Report Top Ranked Heart Hospitals are ABIOMED Customers
06/16/2004
ABIOMED adds three to management team
05/27/2004
ABIOMED Announces Results for Fiscal Year Ended March 31, 2004
05/26/2004
ABIOMED Announces 14th Implant of AbioCor Replacement Heart
05/17/2004
Support Withdrawn for Twelfth AbioCor Patient
05/05/2004
ABIOMED Announces 13th Implant of AbioCor Replacement Heart
04/26/2004
ABIOMED launches AB5000™ Circulatory Support System
04/22/2004
Twelfth AbioCor heart patient reaches 60 day milestone
04/06/2004
ABIOMED Appoints Michael R. Minogue President and CEO
03/16/2004
ABIOMED Announces Recent Hires, March 2004
03/03/2004
ABIOMED Announces 12th Implant of AbioCor replacement heart
02/24/2004
David Gottlieb Joins ABIOMED Board of Directors
02/10/2004
ABIOMED Reports Third Fiscal Quarter Financial Results
01/22/2004
ABIOMED Announces Recent Hires
|